Grifols, S.A. (BME:GRF.P)

Spain · Delayed Price · Currency is EUR

7.82

+0.06 (0.77%)

At close: Feb 26, 2026

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biopharma	6.49B	6.14B	5.56B	5.01B	3.81B
Biopharma Growth	5.60%	10.53%	11.04%	31.20%	-10.08%
Diagnostic	640.00M	645.00M	670.00M	671.29M	779.11M
Diagnostic Growth	-0.78%	-3.73%	-0.19%	-13.84%	0.41%
Bio Supplies	154.00M	216.00M	160.00M	146.08M	115.81M
Bio Supplies Growth	-28.70%	35.00%	9.53%	26.13%	-13.07%
Others	243.00M	208.00M	204.00M	250.17M	266.46M
Others Growth	16.83%	1.96%	-18.45%	-6.12%	19.75%
Intersegments	-	-	-	-8.95M	-43.25M
Total	7.52B	7.21B	6.59B	6.06B	4.93B
Total Growth	4.33%	9.41%	8.71%	22.92%	-7.62%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States + Canada	3.86B	3.15B
United States + Canada Growth	22.22%	-12.37%
Rest of the World	1.18B	872.12M
Rest of the World Growth	34.86%	-3.72%
Spain	320.63M	362.41M
Spain Growth	-11.53%	6.85%
Rest of European Union	711.58M	544.04M
Rest of European Union Growth	30.79%	9.84%
Total	6.06B	4.93B
Total Growth	22.92%	-7.62%

Source: S&P Global Market Intelligence.